Update on infectious diseases affecting the equine nervous system

Veterinary Clinics of North America - Equine Practice

Volumn 27, Issue 3, 2011, Pages 573-587

  Johnson, Amy L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Anaplasma; Equine herpes virus (EHV 1); Equine protozoal myeloencephalitis (EPM); Halicephalobus; Lyme neuroborreliosis; Parelaphostrongylus tenuis; Rabies; West Nile virus (WNV)

Indexed keywords

ANIMAL; ANIMAL DISEASE; HORSE; HORSE DISEASE; MICROBIOLOGY; NEUROLOGIC DISEASE; PARASITOLOGY; REVIEW;

ANIMALS; HORSE DISEASES; HORSES; NERVOUS SYSTEM DISEASES;

ANAPLASMA; EQUID HERPESVIRUS 1; EQUIDAE; HALICEPHALOBUS; PARELAPHOSTRONGYLUS TENUIS; WEST NILE VIRUS;

EID: 81555214705     PISSN: 07490739     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cveq.2011.08.008     Document Type: Review

References (84)

1. Henninger R.W., Reed S.M., Saville W.J., et al. Outbreak of neurologic disease caused by equine herpesvirus-1 at a university equestrian center. J Vet Intern Med 2007, 21:157-165.
2. Goehring L.S., Landolt G.A., Morley P.S. Detection and management of an outbreak of equine herpesvirus type 1 infection and associated neurological disease in a veterinary teaching hospital. J Vet Intern Med 2010, 24:1176-1183.
3. Nugent J., Birch-Machin I., Smith K.C., et al. Analysis of equid herpesvirus 1 strain variation reveals a point mutation of the DNA polymerase strongly associated with neuropathogenic versus nonneuropathogenic disease outbreaks. J Virol 2006, 80:4047-4060.
4. Allen G.P., Breathnach C.C. Quantification by real-time PCR of the magnitude and duration of leucocyte-associated viraemia in horses infected with neuropathogenic vs. non-neuropathogenic strains of EHV-1. Equine Vet J 2006, 38:252-257.
5. Goodman L.B., Loregian A., Perkins G.A., et al. A point mutation in a herpesvirus polymerase determines neuropathogenicity. PLoS Pathog 2007, 3:e160.
6. Perkins G.A., Goodman L.B., Tsujimura K., et al. Investigation of the prevalence of neurologic equine herpes virus type 1 (EHV-1) in a 23-year retrospective analysis (1984-2007). Vet Microbiol 2009, 139:375-378.
7. Allen G.P., Bolin D.C., Bryant U., et al. Prevalence of latent, neuropathogenic equine herpesvirus-1 in the Thoroughbred broodmare population of central Kentucky. Equine Vet J 2008, 40:105-110.
8. Pusterla N., Mapes S., Wilson W.D. Prevalence of equine herpesvirus type 1 in trigeminal ganglia and submandibular lymph nodes of equids examined postmortem. Vet Rec 2010, 167:376-379.
9. Pusterla N., Mapes S., Madigan J.E., et al. Prevalence of EHV-1 in adult horses transported over long distances. Vet Rec 2009, 165:473-475.
10. Yactor J., Lunn K.F., Traub-Dargatz J.L. Detection of nasal shedding of EHV-1 and 4 at equine show events and sales by multiplex real-time PCR. Proceedings of the 52nd Annual Convention of the American Association of Equine Practitioners 2006, 223-227.
11. Hussey S.B., Clark R., Lunn K.F., et al. Detection and quantification of equine herpesvirus-1 viremia and nasal-shedding by real-time polymerase chain reaction. J Vet Diagn Invest 2006, 18:335-342.
12. Allen G.P. Development of a real-time polymerase chain reaction assay for rapid diagnosis of neuropathogenic strains of equine herpesvirus-1. J Vet Diagn Invest 2007, 19:69-72.
13. Lunn D.P., Davis-Poynter N., Flaminio M.J.B.F., et al. Equine herpesvirus-1 consensus statement. J Vet Intern Med 2009, 23:450-461.
14. Bentz B.G., Maxwell L.K., Erkert R.S., et al. Pharmacokinetics of acyclovir after single intravenous and oral administration to adult horses. J Vet Intern Med 2006, 20:589-594.
15. Garre B., Gryspeerdt A., Croubels S., et al. Evaluation of orally administered valacyclovir in experimentally EHV1-infected ponies. Vet Microbiol 2009, 135:214-221.
16. Maxwell L.K., Bentz B.G., Gilliam L.L., et al. Efficacy of valacyclovir against clinical disease after EHV-1 challenge in aged mares. Proceedings of the 54th Annual Convention of the American Association of Equine Practitioners 2008.
17. Brosnahan M.M., Damiani A., van de Walle G., et al. The effect of siRNA treatment on experimental equine herpesvirus type 1 (EHV-1) infection in horses. Virus Res 2010, 147:176-181.
18. Goodman L.B., Wagner B., Flaminio M.J., et al. Comparison of the efficacy of inactivated combination and modified-live virus vaccines against challenge infection with neuropathogenic equine herpesvirus type 1 (EHV-1). Vaccine 2006, 24:3636-3645.
19. Goehring L.S., Wagner B., Bigbie R., et al. Control of EHV-1 viremia and nasal shedding by commercial vaccines. Vaccine 2010, 28:5203-5211.
20. Outbreak of West Nile-like viral encephalitis-New York, 1999. MMWR 1999, 48:845-849. Centers for Disease Control and Prevention.
21. West Nile virus activity-United States, 2009. MMWR 2010, 59:769-772. Centers for Disease Control and Prevention.
22. Ostlund E.N., Andresen J.E., Andresen M. West Nile encephalitis. Vet Clin North Am Equine Pract 2000, 16:427-441.
23. Ward M.P., Schuermann J.A., Highfield L.D., et al. Characteristics of an outbreak of West Nile virus encephalomyelitis in a previously uninfected population of horses. Vet Microbiol 2006, 118:255-259.
24. Long M.T., Jeter W., Hernandez J., et al. Diagnostic performance of the equine IgM capture ELISA for serodiagnosis of West Nile virus infection. J Vet Intern Med 2006, 20:608-613.
25. Porter M.B., Long M., Gosche D.G., et al. Immunoglobulin M-capture enzyme-linked immunosorbent assay testing of cerebrospinal fluid and serum from horses exposed to West Nile virus by vaccination or natural infection. J Vet Intern Med 2004, 18:866-870.
26. Ben-Nathan D., Samina I., Orr N. High titer human immunoglobulin as a specific therapy against West Nile virus encephalitis. Hum Vaccin 2010, 6:279-281.
27. Salazar P., Traub-Dargatz J.L., Morley P.S., et al. Outcome of equids with clinical signs of West Nile virus infection and factors associated with death. J Am Vet Med Assoc 2004, 225:267-274.
28. Chenier S., Cote G., Vanderstock J., et al. An eastern equine encephalomyelitis (EEE) outbreak in Quebec in the fall of 2008. Can Vet J 2010, 51:1011-1015.
29. Gibney KB, Robinson S, Mutebi JP, et al. Eastern equine encephalitis: an emerging arboviral disease threat, Maine, 2009. Vector Borne Zoonotic Dis. doi:10.1089/vbz.2010.0189.
30. Larkin M. High prevalence of EEE in Michigan. J Am Vet Med Assoc 2010, 237:1001.
31. Calisher C.H., Mahmud M.I., el-Kafrawi A.O., et al. Rapid and specific serodiagnosis of western equine encephalitis virus infection in horses. Am J Vet Res 1986, 47:1296-1299.
32. Sahu S.P., Alstad A.D., Pedersen D.D., et al. Diagnosis of eastern equine encephalomyelitis virus infection in horses by immunoglobulin M and G capture enzyme-linked immunosorbent assay. J Vet Diagn Invest 1994, 6:34-38.
33. Blanton J.D., Palmer D., Rupprecht C.E. Rabies surveillance in the United States during 2009. J Am Vet Med Assoc 2010, 237:646-657.
34. Carrieri M.L., Peixoto Z.M., Paciencia M.L., et al. Laboratory diagnosis of equine rabies and its implications for human postexposure prophylaxis. J Virol Methods 2006, 138:1-9.
35. Brito M.G., Chamone T.L., Silva F.J., et al. Antemortem diagnosis of human rabies in a veterinarian infected when handling a herbivore in Minas Gerais, Brazil. Rev Inst Med Trop Sao Paulo 2011, 53:39-44.
36. Hudson L.C., Weinstock D., Jordan T., et al. Clinical presentation of experimentally induced rabies in horses. Zentralbl Veterinarmed B 1996, 43:277-285.
37. O'Toole D., Mills K., Ellis J., et al. Poliomyelomalacia and ganglioneuritis in a horse with paralytic rabies. J Vet Diagn Invest 1993, 5:94-97.
38. Green S.L., Smith L.L., Vernau W., et al. Rabies in horses: 21 cases (1970-1990). J Am Vet Med Assoc 1992, 200:1133-1137.
39. Wilson P.J., Oertli E.H., Hunt P.R., et al. Evaluation of a postexposure rabies prophylaxis protocol for domestic animals in Texas: 2000-2009. J Am Vet Med Assoc 2010, 237:1395-1401.
40. Madigan J.E., Pusterla N. Ehrlichial diseases. Vet Clin North Am Equine Pract 2000, 16:487-499.
41. Nolen-Walston R.D., D'Oench S.M., Hanelt L.M., et al. Acute recumbency associated with Anaplasma phagocytophilum infection in a horse. J Am Vet Med Assoc 2004, 224:1964-1966.
42. Hilton H., Madigan J.E., Aleman M. Rhabdomyolysis associated with Anaplasma phagocytophilum infection in a horse. J Vet Intern Med 2008, 22:1061-1064.
43. Madigan J.E., Gribble D. Equine ehrlichiosis in northern California: 49 cases (1968-1981). J Am Vet Med Assoc 1987, 190:445-448.
44. Franzen P., Aspan A., Egenvall A., et al. Molecular evidence for persistence of Anaplasma phagocytophilum in the absence of clinical abnormalities in horses after recovery from acute experimental infection. J Vet Intern Med 2009, 23:636-642.
45. Johnson A.L., Divers T.J., Chang Y.F. Validation of an in-clinic enzyme-linked immunosorbent assay kit for diagnosis of Borrelia burgdorferi infection in horses. J Vet Diagn Invest 2008, 20:321-324.
46. Burgess E.C. Borrelia burgdorferi infection in Wisconsin horses and cows. Ann NY Acad Sci 1988, 539:235-243.
47. Butler C.M., Houwers D.J., Jongejan F., et al. Borrelia burgdorferi infections with special reference to horses: a review. The Veterinary Quarterly 2005, 27:146-156.
48. Magnarelli L.A., Anderson J.F., Shaw E., et al. Borreliosis in equids in northeastern United States. Am J Vet Res 1988, 49:359-362.
49. Hahn C.N., Mayhew I.G., Whitwell K.E., et al. A possible case of Lyme borreliosis in a horse in the UK. Equine Vet J 1996, 28:84-88.
50. James F.M., Engiles J.B., Beech J. Meningitis, cranial neuritis, and radiculoneuritis associated with Borrelia burgdorferi infection in a horse. J Am Vet Med Assoc 2010, 237:1180-1185.
51. Imai D.M., Barr B.C., Daft B., et al. Lyme neuroborreliosis in 2 horses. Vet Pathol 2011 Apr 1, [Epub ahead of print]. 10.1177/0300985811398246.
52. Wagner B., Freer H., Rollins A., et al. A fluorescent bead-based multiplex assay for the simultaneous detection of antibodies to B. burgdorferi outer surface proteins in canine serum. Vet Immunol Immunopathol 2011, 140:190-198.
53. Chang Y.F., Ku Y.W., Chang C.F., et al. Antibiotic treatment of experimentally Borrelia burgdorferi-infected ponies. Vet Microbiol 2005, 107:285-294.
54. Schnabel L.V., Fortier L.A., Papich M.G., et al. Pharmacokinetics and distribution of minocycline into the plasma, synovial fluid, cerebral spinal fluid and aqueous humor after oral administration of multiple doses in horses. Poster presentation, ACVS Veterinary Symposium 2010.
55. Finno C.J., Aleman M., Pusterla N. Equine protozoal myeloencephalitis associated with neosporosis in 3 horses. J Vet Intern Med 2007, 21:1405-1408.
56. Johnson A.L., Burton A.J., Sweeney R.W. Utility of 2 immunological tests for antemortem diagnosis of equine protozoal myeloencephalitis (Sarcocystis neurona infection) in naturally occurring cases. J Vet Intern Med 2010, 24:1184-1189.
57. Furr M., MacKay R., Granstrom D., et al. Clinical diagnosis of equine protozoal myeloencephalitis (EPM). J Vet Intern Med 2002, 16:618-621.
58. Daft B.M., Barr B.C., Gardner I.A., et al. Sensitivity and specificity of western blot testing of cerebrospinal fluid and serum for diagnosis of equine protozoal myeloencephalitis in horses with and without neurologic abnormalities. J Am Vet Med Assoc 2002, 221:1007-1013.
59. Miller M.M., Sweeney C.R., Russell G.E., et al. Effects of blood contamination of cerebrospinal fluid on Western blot analysis for detection of antibodies against Sarcocystis neurona and on albumin quotient and immunoglobulin G index in horses. J Am Vet Med Assoc 1999, 215:67-71.
60. Duarte P.C., Daft B.M., Conrad P.A., et al. Comparison of a serum indirect fluorescent antibody test with two Western blot tests for the diagnosis of equine protozoal myeloencephalitis. J Vet Diagn Invest 2003, 15:8-13.
61. Ellison S.P., Kennedy T., Brown K.K. Development of an ELISA to detect antibodies to rSAG1 in the horse. Int J Appl Res Vet Med 2003, 1:318-327.
62. Finno C.J., Packham A.E., Wilson W.D., et al. Effects of blood contamination of cerebrospinal fluid on results of indirect fluorescent antibody tests for detection of antibodies against Sarcocystis neurona and Neospora hughesi. J Vet Diagn Invest 2007, 19:286-289.
63. Crowdus C.A., Marsh A.E., Saville W.J., et al. SnSAG5 is an alternative surface antigen of Sarcocystis neurona strains that is mutually exclusive to SnSAG1. Vet Parasitol 2008, 158:36-43.
64. Wendte J.M., Miller M.A., Nandra A.K., et al. Limited genetic diversity among Sarcocystis neurona strains infecting southern sea otters precludes distinction between marine and terrestrial isolates. Vet Parasitol 2010, 169:37-44.
65. Hoane J.S., Morrow J.K., Saville W.J., et al. Enzyme-linked immunosorbent assays for detection of equine antibodies specific to Sarcocystis neurona surface antigens. Clin Diagn Lab Immunol 2005, 12:1050-1056.
66. Yeargan M.R., Howe D.K. Improved detection of equine antibodies against Sarcocystis neurona using polyvalent ELISAs based on the parasite SnSAG surface antigens. Vet Parasitol 2011, 176:16-22.
67. Reed S.M., Howe D.K., Yeargan M.R., et al. New quantitative assays for the differential diagnosis of equine protozoal myeloencephalitis (EPM). EPM Special Interest Group (SIG) at American College of Veterinary Internal Medicine Forum 2010.
68. Furr M., Howe D., Reed S., et al. Antibody coefficients for the diagnosis of equine protozoal myeloencephalitis. J Vet Intern Med 2011, 25:138-142.
69. Freedom of information summary, NADA 141-240. REBALANCE Antiprotozoal Oral Suspension (sulfadiazine and pyrimethamine) "for the treatment of horses with equine protozoal myeloencephalitis (EPM) caused by Sarcocystis neurona." 2004, Animal Health Pharmaceuticals, Animal Health Pharmaceuticals, St Joseph (MT).
70. Fenger C.K., Granstrom D.E., Langemeier J.L., et al. Epizootic of equine protozoal myeloencephalitis on a farm. J Am Vet Med Assoc 1997, 210:923-927.
71. Piercy R.J., Hinchcliff K.W., Reed S.M. Folate deficiency during treatment with orally administered folic acid, sulphadiazine and pyrimethamine in a horse with suspected equine protozoal myeloencephalitis (EPM). Equine Vet J 2002, 34:311-316.
72. Bedford S.J., McDonnell S.M. Measurements of reproductive function in stallions treated with trimethoprim-sulfamethoxazole and pyrimethamine. J Am Vet Med Assoc 1999, 215:1317-1319.
73. Toribio R.E., Bain F.T., Mrad D.R., et al. Congenital defects in newborn foals of mares treated for equine protozoal myeloencephalitis during pregnancy. J Am Vet Med Assoc 1998, 212:697-701.
74. Furr M., Kennedy T., MacKay R., et al. Efficacy of ponazuril 15% oral paste as a treatment for equine protozoal myeloencephalitis. Vet Ther 2001, 2:215-222.
75. Dirikolu L., Karpiesiuk W., Lehner A.F., et al. Synthesis and detection of toltrazuril sulfone and its pharmacokinetics in horses following administration in dimethylsulfoxide. J Vet Pharmacol Ther 2009, 32:368-378.
76. Freedom of information summary, NADA 141-178. NAVIGATOR (32% nitazoxanide) Antiprotozoal Oral Paste "for the treatment of horses with equine protozoal myeloencephalitis (EPM) caused by Sarcocystis neurona." 2003, IDEXX Pharmaceuticals, Inc, IDEXX Pharmaceuticals, Greensboro (NC).
77. Freedom of information summary, NADA 141-268. PROTAZIL Anti-protozoal Pellets (1.56% diclazuril) "for the treatment of equine protozoal myeloencephalitis (EPM) caused by Sarcocystis neurona in horses." 2007, Schering-Plough Animal Health Corporation, Schering-Plough Animal Health Corporation, Langehorne (PA).
78. Van Biervliet J., de Lahunta A., Ennulat D., et al. Acquired cervical scoliosis in six horses associated with dorsal grey column chronic myelitis. Equine Vet J 2004, 36:86-92.
79. Tanabe M., Kelly R., de Lahunta A., et al. Verminous encephalitis in a horse produced by nematodes in the family protostrongylidae. Vet Pathol 2007, 44:119-122.
80. Johnson A.L., de Lahunta A., Divers T.J. Acquired scoliosis in horses: case series and proposed pathogenesis. AAEP Proc 2008, 54:192-197.
81. Reinstein S.L., Lucio-Forster A., Bowman D.D., et al. Surgical extraction of an intraocular infection of Parelaphostrongylus tenuis in a horse. J Am Vet Med Assoc 2010, 237:196-199.
82. Tanabe M., Gerhold R.W., Beckstead R.B., et al. Molecular confirmation of Parelaphostrongylus tenuis infection in a horse with verminous encephalitis. Vet Pathol 2010, 47:759.
83. Ferguson R., van Dreumel T., Keystone J.S., et al. Unsuccessful treatment of a horse with mandibular granulomatous osteomyelitis due to Halicephalobus gingivalis. Can Vet J 2008, 49:1099-1103.
84. Johnson J.S., Hibler C.P., Tillotson K.M., et al. Radiculomeningomyelitis due to Halicephalobus gingivalis in a horse. Vet Pathol 2001, 38:559-561.